|
Media
Contacts:
Dr. Charles
Opperman, 919/515-6699
Dr. Steve Lommel,
919/515-6990
Dave Caldwell,
Communication Services, 919/513-3127
Dec.
11, 2002
Philip
Morris USA Provides $17.6 Million for Tobacco Genome
Mapping
FOR
IMMEDIATE RELEASE
North
Carolina State University and Philip Morris USA have
reached an agreement under which the tobacco company
will provide $17.6 million over 4 1/2 years to fund
a project to map the genome of tobacco.
The
Tobacco Genome Initiative will be carried out in the
College of Agriculture and Life Sciences at NC State
and will take advantage of the college's rapidly emerging
expertise in genomic sciences, said Dr. Steven Lommel,
assistant vice chancellor for research. The contract
is the largest ever signed for a research effort in
the College of Agriculture and Life Sciences and among
the largest for the university.
"This
initiative marks a milestone in NC State's emergence
as a national leader in genomic research, and opens
a new chapter in our understanding of the tobacco genome,"
said NC State Chancellor Marye Anne Fox. "By placing
all new information from this study into the public
domain, scientists, farmers, businesses and students
worldwide will benefit from NC State's discoveries."
"The
idea is to make a physical map of the tobacco genome
and to sequence as many genes as possible," said
Dr. Charles Opperman, professor of plant pathology and
genetics. Opperman will lead the project.
"Tobacco
is an important model system. It's used to study other
plants that may be more difficult to work with,"
Opperman added. "The data derived from this project
will be important to plant scientists working with a
number of other plants, studying how other species develop,
yield, resist pests and pathogens, and many other areas."
With completion of the project, tobacco will be among
a handful of plants whose genomes have been mapped.
The genomes of rice and a plant called Arabidopsis have
been mapped, while mapping the genome of corn is well
under way, Lommel said. Arabidopsis is a weed that is
a member of the mustard family. It is often used as
a model plant.
"We
hope to sequence over 90 percent of tobacco's genes,"
said Opperman. "This does not mean we'll know what
all the genes do, although in some cases we will be
able to determine gene function."
It's
not clear now many genes a tobacco plant has, Opperman
added, although it is thought tobacco has between 25,000
and 50,000 genes.
Both
Opperman and Lommel said the information produced by
the project should be valuable to scientists working
with a range of other plants. They pointed out that
plants such as tomatoes, potatoes and peppers are relatives
of tobacco, so much that is learned from the Tobacco
Genome Initiative may be directly applicable to gaining
a better understanding of how these tobacco relatives
function.
"The
genome map hands you the keys to do a whole range of
experiments," Opperman said. He added that knowing
where a gene lies in the genome often provides clues
as to how the gene works and what it does.
"And
we'll probably discover novel genes during the project,"
he said, adding that the project may aid in understanding
how plants and other organisms evolve.
At
the same time, the project is likely to provide information
that may lead to genetic engineering of tobacco for
alternative uses. Tobacco is thought to be a promising
candidate for molecular farming. It may be possible
to change the genetic makeup of tobacco plants so that
the plants produce valuable chemicals or drugs. The
plants would then be harvested and processed for these
chemicals or drugs.
While
the Tobacco Genome Initiative will be headquartered
in Opperman's laboratory, it will take advantage of
relatively new facilities in the College of Agriculture
and Life Sciences such as the Genome Research Laboratory,
a 4,000-square-foot, $3 million lab on NC State's Centennial
Campus that makes available to college researchers the
latest genomic technology.
Opperman
added that Orion Genomics, a St. Louis, Mo., company,
will also play a key role in the project. NC State has
contracted with Orion for use of the company's proprietary
Gene Thresher technology that identifies gene-rich regions
of a genome. Only about 1 percent of the tobacco genome
is thought to contain genes, so the technology will
help narrow the search for genes.
The
signing of the agreement comes at the conclusion of
a year-long pilot study.
"We
developed some of the tools we'll need for the project,"
said Opperman. "We tried out sequencing strategies,
developed some physical infrastructure and data analysis
tools. The first year was basically a feasibility study.
Could we scale up and do this? The answer was 'yes.'"
-
caldwell -
|